News
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks
"If you don't find a way to make money while you sleep, you will work until you die." That's a quote from billionaire investor Warren Buffett which emphasizes the importance of making your money
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks
"If you don't find a way to make money while you sleep, you will work until you die." That's a quote from billionaire investor Warren Buffett which emphasizes the importance of making your money
Merck (MRK) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q1 2024 Earnings CallApr 25, 2024, 9:00 a.m. ET
Operator
Source Fool.com
2 Fantastic Growth Stocks to Buy Right Now
While some stocks have responded to the 2024 bull market better than others, an abundance of stocks have followed this rising tide. There's no predicting how long this next bull market will last
2 Fantastic Growth Stocks to Buy Right Now
While some stocks have responded to the 2024 bull market better than others, an abundance of stocks have followed this rising tide. There's no predicting how long this next bull market will last
2 Fantastic Growth Stocks to Buy Right Now
While some stocks have responded to the 2024 bull market better than others, an abundance of stocks have followed this rising tide. There's no predicting how long this next bull market will last
Why Biogen Stock Leaped Nearly 5% Higher Today
Before market open on Wednesday, Biogen (NASDAQ: BIIB) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and investors rewarded
Why Biogen Stock Leaped Nearly 5% Higher Today
Before market open on Wednesday, Biogen (NASDAQ: BIIB) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and investors rewarded
Why Biogen Stock Leaped Nearly 5% Higher Today
Before market open on Wednesday, Biogen (NASDAQ: BIIB) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and investors rewarded
Biogen (BIIB) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q1 2024 Earnings CallApr 24, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Biogen (BIIB) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q1 2024 Earnings CallApr 24, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Biogen (BIIB) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q1 2024 Earnings CallApr 24, 2024, 8:30 a.m. ET
Operator
Source Fool.com
EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth
EQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
EQS-Adhoc: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic fibrosis (CF). The biotech is the market leader, bringing in billions of dollars in revenue and profit
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic fibrosis (CF). The biotech is the market leader, bringing in billions of dollars in revenue and profit
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic fibrosis (CF). The biotech is the market leader, bringing in billions of dollars in revenue and profit
Buying the Dip in These 3 Undervalued Dividend Stocks
We have seen a stock pullback here in April, and three of these high-quality dividend paying stocks look quite intriguing. One of those stocks is healthcare company AbbVie (NYSE: ABBV) which I
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
Vertex Pharmaceuticals (NASDAQ: VRTX) has been through some ups and downs over the past few years. The big biotech disappointed investors when a couple of candidates outside of its specialty area of
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
Vertex Pharmaceuticals (NASDAQ: VRTX) has been through some ups and downs over the past few years. The big biotech disappointed investors when a couple of candidates outside of its specialty area of
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
Vertex Pharmaceuticals (NASDAQ: VRTX) has been through some ups and downs over the past few years. The big biotech disappointed investors when a couple of candidates outside of its specialty area of
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
As investing legends like Warren Buffett probably know better than anyone, there's something satisfying about buying shares of a company you intend to hold for the rest of your career as an